KMDA Q4 2018 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

Q4 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$48M+35.0% YoY

Gross Profit

$21M44.1% margin

Operating Income

$15M31.9% margin

Net Income

$18M36.8% margin

EPS (Diluted)

$0.44

QoQ Revenue Growth

+221.9%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$6M

Stock-Based Comp.

$269,000

Balance Sheet

Total Assets

$138M

Total Liabilities

$26M

Stockholders' Equity

$112M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$36M	+35.0%
Gross Profit	$21M	$12M	+82.8%
Operating Income	$15M	$6M	+138.7%
Net Income	$18M	$6M	+183.8%